Clover Co. Limited (ASX:CLV) insider Rupert Harrington acquired 11,003 shares of the company’s stock in a transaction on Friday, November 2nd. The stock was bought at an average cost of A$1.45 ($1.03) per share, with a total value of A$15,954.35 ($11,315.14).

ASX CLV traded up A$0.01 ($0.01) during midday trading on Friday, hitting A$1.48 ($1.05). The company had a trading volume of 188,378 shares, compared to its average volume of 127,440. The company has a quick ratio of 2.28, a current ratio of 4.29 and a debt-to-equity ratio of 10.98. Clover Co. Limited has a twelve month low of A$0.36 ($0.26) and a twelve month high of A$0.74 ($0.52).

Get Clover alerts:

ILLEGAL ACTIVITY WARNING: This story was published by American Banking News and is the property of of American Banking News. If you are accessing this story on another site, it was copied illegally and republished in violation of international trademark and copyright law. The original version of this story can be viewed at https://www.americanbankingnews.com/2018/11/10/rupert-harrington-buys-11003-shares-of-clover-co-limited-clv-stock.html.

About Clover

Clover Corporation Limited refines and sells natural oils in Australia, New Zealand, Asia, Europe, and the Americas. The company is also involved in the production of encapsulated powders; and research and product development of functional food and infant nutrition ingredients. It offers Nu-Mega Hi docosahexaenoic acid tuna oils for use in infant formula and pharmaceutical products; Ocean Gold refined tuna oils; Nu-Mega Driphorm powders that are used in a range of infant formula, follow-on formula, growing up milk products, and food applications; and Nu-Mega Driphorm HA for non-dairy applications.